JOSEPH HORVATH: Open Payments
NPI 1568858629 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$518 in 26 payments from 6 companies in 2025. Trend: 2023 $92 · 2024 $122 · 2025 $518
Food & beverage: $518
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $216 |
| Otsuka America Pharmaceutical, Inc. | 7 | $144 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $58 |
| Axsome Therapeutics, Inc. | 2 | $44 |
| Corium, LLC | 1 | $32 |
| Almatica Pharma LLC | 1 | $24 |
Products named: VRAYLAR, ABILIFY ASIMTUFII, REXULTI, CAPLYTA, Auvelity, Azstarys, LOREEV XR.
Industry payments across CO — which companies pay providers there.
